Company profile: 1-800-PetMeds
1.1 - Company Overview
Company description
- Provider of pet food for dogs and cats and a range of pet health products, including flea and tick control and treatments, heartworm prevention, pain relief medications, urinary tract and kidney medications, and dewormers for dogs and cats.
Products and services
- Dewormers for Dogs & Cats: Species-specific deworming products for dogs and cats that eliminate worm infestations and support pet health through effective parasite control
- Flea & Tick Control and Treatments: Targeted products that control and treat flea and tick infestations in pets, reducing parasite presence to improve comfort and health
- Heartworm Prevention for Dogs & Cats: Preventive medications for dogs and cats that help prevent heartworm disease, delivering ongoing protection against parasitic infection in pets
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to 1-800-PetMeds
Genoscoper
HQ: Finland
Website
- Description: Provider of animal diagnostics with the world's first commercially available genome-wide DNA analysis for companion animals. Established in 1995, it uses a comprehensive panel approach to test for known mutations and explore inherited characteristics. Products include the Breeds & Health Kit for dogs, which screens for over 140 health conditions and provides detailed health reports.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Genoscoper company profile →
Otto
HQ: United States
Website
- Description: Provider of an integrated mobile app extension to existing veterinarian practice management systems.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Otto company profile →
Addition Technology
HQ: United States
Website
- Description: Provider of ophthalmic medical devices, specializing in Intacs corneal implants, the only FDA-approved intracorneal segments, for minimally invasive stabilization of keratoconus. Also offers veterinary ophthalmic devices, including canine and feline intraocular lenses, capsular tension rings, and collagen membranes for corneal repair. Products are single-use, sterile, ready to use in glass vials.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Addition Technology company profile →
Assisi Veterinary System
HQ: United Kingdom
Website
- Description: Provider of veterinary management software designed to support all practice types, including small animal, farm, and equine.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Assisi Veterinary System company profile →
NexGen Pharmaceuticals
HQ: United States
Website
- Description: Provider of an animal health technology digital platform and prescription management ecosystem for large and exotic animals, offering access to veterinarians and wildlife handlers and integrating products, services, and a knowledge base. Portfolio includes parasite control injectables (LongRange, Noromectin), sedatives (XylaMed), antiparasitic powders (Fenbendazole), diuretics (Furosemide), and metronidazole oral suspensions.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full NexGen Pharmaceuticals company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for 1-800-PetMeds
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to 1-800-PetMeds
2.2 - Growth funds investing in similar companies to 1-800-PetMeds
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for 1-800-PetMeds
4.2 - Public trading comparable groups for 1-800-PetMeds
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →